
Latest stock market news, company updates, and price movements. Stay updated with market trends, earnings insights, and investment analysis.
US strikes and Iranian ship seizures revived uncertainty in the Strait of Hormuz, disrupting India-bound cargoes and raising risks for oil supply and freight rates.
PNC Infratech remains in focus as brokerages reiterate mostly positive calls after Q4, citing an ₹18,000 crore order book, execution recovery hopes, and multiple targets.
RBI says 98.47% of Rs 2,000 notes have returned, with Rs 5,451 crore still in circulation as of April 30, 2026, while remaining legal tender.
Social media and broker notes are converging on 22,000 as a key Nifty support, while 24,600 remains the breakout level to watch for trend clarity.
Rallis India is hiking product prices to offset a 15-25% rise in raw material costs amid Middle East supply disruptions, while analysts flag monsoon and China-led competition risks.
Social media debates are centring on whether Nifty can revisit 22,000 in 2026, as analysts map key supports near 23,000 and resistance at 24,600.
HDFC Bank is back in focus as it builds an in-house AI platform and real-time fraud monitoring, with investors tracking disclosures, governance changes and tech-led execution amid firmer markets.
KP Green Engineering disclosed fresh orders worth ₹239.61 crore across solar mounting structures, crash barriers and transmission equipment, with execution scheduled during the current financial year.
India’s Q1FY27 earnings season accelerates with 140+ companies reporting from July 13-18, led by Reliance, HCLTech, Wipro, Tech Mahindra, BHEL and top private banks.
Social chatter around Bank Nifty is converging on rule-based 0-3 DTE bots that combine gamma-heavy strikes with volatility compression, breakout triggers, and strict intraday exits.
Prime Focus said it deposited ₹353.79 crore as directed by NCLAT, which has stayed NCLT Mumbai’s insolvency order and restrained the IRP until July 9, 2026.
Sandu Pharmaceuticals will hold a July 11, 2026 board meeting to record the demise of MD Umesh B. Sandu and consider leadership and governance changes.
Sandu Pharmaceuticals will meet on July 11, 2026 to appoint a new Managing Director after Umesh B. Sandu’s demise, and to reshuffle board committees.
Sandu Pharmaceuticals scheduled a July 11, 2026 board meeting to place on record Managing Director Umesh B. Sandu’s June 19 demise and note his contributions.
Sandu Pharmaceuticals will meet on July 11, 2026 to appoint a new Managing Director after Umesh B. Sandu’s death, and review committee and director changes.
NTPC’s board cleared ₹20,456.70 crore for Lara Stage-III (2x800 MW) in Raigarh, Chhattisgarh, and disclosed the decision to BSE and NSE under SEBI Regulation 30.